Azithromycin Combix 500 mg film-coated tablets EFG

Spain
Brand name Azithromycin Combix 500 mg film-coated tablets EFG
Form tablets, film-coated
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 76718
Azithromycin Combix 500 mg film-coated tablets EFG tablets, film-coated

Package leaflet: Information for the user

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Azithromycin Combix 500 mg film-coated tablets EFG

azithromycin (as dihydrate)

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

  1. What Azithromycin Combix is and what it is used for
  2. What you need to know before taking Azithromycin Combix
  3. How to take Azithromycin Combix
  4. Possible side effects
  5. How to store Azithromycin Combix
  6. Contents of the pack and other information

1. What Azitromicina Combix is and what it is used for

This medicine contains the active substance azithromycin. Azithromycin is an antibiotic that belongs to a group of antibiotics known as macrolides, which block the growth of susceptible bacteria.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as influenza or the common cold.

It is important to follow your doctor's instructions regarding dosage, dosing intervals, and duration of treatment.

Do not store or reuse this medicine. If you have leftover antibiotics after completing the treatment, return them to the pharmacy for proper disposal. Medicines must not be disposed of via wastewater or household waste.

Azithromycin is indicated for the treatment of the following infections:

Adults and adolescents weighing over 45 kg

  • Infection of the tonsils (tonsillitis) or throat (pharyngitis) caused by streptococcal bacteria
  • Bacterial infection of the nasal sinuses (sinusitis)
  • Bacterial middle ear infection (otitis media)
  • Pneumonia (community-acquired pneumonia, not contracted in a hospital)
  • Bacterial infection of the skin and underlying tissues
  • Infection of the urethra and cervix caused by Chlamydia trachomatis bacteria

Adults

  • Bacterial infection in patients with prolonged lung inflammation (chronic bronchitis)

2. What you need to know before taking Azitromicina Combix

Do not take Azitromicina Combix

  • if you are allergic to azithromycin, erythromycin, any other macrolide or ketolide antibiotic, or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting azithromycin if you have or have had any of the following conditions:

  • heart problems (e.g., heart rhythm disorders or heart failure) or low levels of potassium or magnesium in the blood: these conditions may contribute to serious cardiac adverse effects of azithromycin;
  • liver problems: your doctor may need to monitor your liver function or discontinue treatment;
  • severe diarrhea after taking any other antibacterial agent;
  • localized muscle weakness (myasthenia gravis), as symptoms of this disease may worsen during treatment;
  • or if you are being treated with any ergot derivative such as ergotamine (used to treat migraines), as these medicines should not be taken with azithromycin.

Stop taking this medicine and contact your doctor immediately (see also “Serious adverse reactions” in section 4):

  • if you think you are having an allergic reaction (e.g., difficulty breathing, swelling of the face or throat, rash or blistering);
  • if you notice any of the symptoms described in section 4 related to serious skin reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), or acute generalized exanthematous pustulosis (AGEP);
  • if you think your heartbeat is irregular or you experience palpitations, dizziness, or fainting during treatment with azithromycin;
  • if you develop signs of liver problems (e.g., dark urine, loss of appetite, or yellowing of the skin or whites of the eyes);
  • if you develop severe diarrhea during or after treatment. Do not take any medication for diarrhea without first speaking to your doctor. If your diarrhea persists or recurs within the first few weeks after treatment, inform your doctor as well.

Superinfection

Your doctor may monitor you for signs of additional bacterial or fungal infections that cannot be treated with azithromycin (superinfection).

Sexually transmitted infections

Your doctor may perform tests to rule out possible syphilis, a sexually transmitted infection that could otherwise progress undetected and be diagnosed late. Additionally, in cases of sexually transmitted bacterial infections, your doctor will initiate follow-up laboratory tests to monitor treatment success.

Children and adolescents

If you weigh less than 45 kg, there are other azithromycin-containing medicines that may be more suitable for your treatment.

Other medicines and Azitromicina Combix

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicine.

Using azithromycin with other medicines may lead to adverse effects. Therefore, it is especially important that you inform your doctor if you are taking any of the following medicines:

  • Atorvastatin and other medicines in the statin group (to reduce blood cholesterol levels and prevent heart disease, including heart attacks and stroke)

  • Cyclosporine (to prevent organ transplant rejection)

  • Colchicine (for the treatment of gout and familial Mediterranean fever)

  • Dabigatran (to prevent and treat blood clot formation [anticoagulant])

  • Digoxin (for the treatment of heart conditions)

  • Warfarin or similar medicines used to thin the blood (anticoagulants)

  • Medicines that may prolong the QT interval (i.e., delay the heart muscle's contraction and relaxation), such as:

  • Quinidine, procainamide, dofetilide, amiodarone, and sotalol (for treating irregular heartbeat, such as too fast or too slow: cardiac arrhythmia)

  • Pimozide (for treating mental illnesses)

  • Citalopram (for treating depression)

  • Moxifloxacin and levofloxacin (antibacterial agents)

  • Cisapride (for treating gastrointestinal disorders)

  • Hydroxychloroquine or chloroquine (for treating certain autoimmune diseases such as rheumatoid arthritis, or for treating or preventing malaria).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Pregnancy

Your doctor will assess whether you should take this medicine during pregnancy only after ensuring that the benefits of treatment outweigh any potential risks.

Breastfeeding

Azithromycin is excreted in breast milk. Therefore, your doctor will decide whether to discontinue breastfeeding or avoid treatment with azithromycin, taking into account both the benefit of breastfeeding for your child and the benefit of treatment for you.

Driving and using machines

The effect of azithromycin on the ability to drive and use machines is moderate. Dizziness, somnolence, and seizures, as well as vision and hearing disturbances, have been reported with azithromycin in some individuals. These possible adverse effects may affect your ability to drive and use machines.

Azitromicina Combix contains lactose

If your doctor has diagnosed you with an intolerance to certain sugars, consult with them before taking this medicine.

3. How to take Azithromycin Combix

Follow exactly the instructions for use of this medicine given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

The amount of azithromycin you need to take each day will depend on the bacterial infection being treated and the specific treatment course your doctor or pharmacist has instructed you to follow.

Adults and adolescents weighing at least 45 kg

Infection

Course of azithromycin treatment

Streptococcal bacterial infection of the tonsils (tonsillitis) or throat (pharyngitis)

Bacterial infection of the sinuses (sinusitis)

Bacterial infection of the middle ear (otitis media)

Bacterial infection in patients with prolonged lung inflammation (chronic bronchitis)*

Pneumonia (community-acquired pneumonia, not contracted in hospital) #

Bacterial skin infection and underlying tissues

For these infections, a 3-day or 5-day treatment course is established, and the daily dosage of azithromycin to be taken during these treatment courses is described below.

3-day treatment course

500 mg once daily for 3 days

Bacterial infection of the urethra and cervix caused by Chlamydia trachomatis bacteria

1,000 mg as a single dose

  • For adult patients only.

# In adult patients, initial intravenous treatment may be followed by oral therapy.

Use in children and adolescents

If your weight is less than 45 kg or you are unable to swallow this medicine, consult your doctor or pharmacist, as there are other azithromycin-containing medicines that may be more suitable for you.

Method of administration

For oral use.

Azitromicina Combix should be administered as a single daily dose orally. The tablets must be swallowed whole with water, with or without food. Taking this medicine just before a meal may help improve stomach tolerability.

If you take more Azitromicina Combix than you should

If you take more azithromycin than you should, you may feel unwell. Typical signs of overdose include vomiting, diarrhoea, abdominal pain and nausea. Inform your doctor or contact the nearest hospital emergency department immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Azitromicina Combix

If you forget to take azithromycin, take it as soon as possible, provided that it is at least 12 hours before the next dose. If less than 12 hours remain before the next dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose to make up for a missed dose.

If you stop taking Azitromicina Combix

If you stop treatment with azithromycin too early, the infection may recur. Take azithromycin for the full duration of treatment, even if you start to feel better.

If you have any further questions about the use of this medicine, consult your doctor, pharmacist or nurse.

4. Possible adverse effects

Like all medicines, azithromycin can cause adverse effects, although not everyone experiences them.

Serious adverse effects

Stop taking azithromycin and seek immediate medical attention if you notice any of the following symptoms:

  • sudden chest pain, difficulty breathing, swelling of the eyelids, face or lips, skin rash or itching affecting especially the whole body (anaphylactic reaction, frequency not known).

  • rapid or irregular heartbeat (cardiac arrhythmia or torsade de pointes, tachycardia, frequency not known).

  • dark urine, loss of appetite, or yellowing of the skin or whites of the eyes, which are signs of liver disease (hepatic failure or hepatic necrosis, frequency not known).

  • severe diarrhoea with abdominal cramps, bloody stools or fever, which may indicate an infection in the large intestine (antibiotic-associated colitis, frequency not known). Do not take anti-diarrhoeal medicines that inhibit defecation (antiperistaltics).

  • flat red spots, target-shaped or circular skin lesions on the trunk, often with central blisters, skin peeling, and ulcers in the mouth, throat, nose, genitals and eyes. These serious skin rashes may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome or toxic epidermal necrolysis, frequency not known).

  • widespread rash, high body temperature and enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome, rare [may affect up to 1 in 1,000 people]).

  • widespread red, scaly rash with swellings under the skin and blisters accompanied by fever. Symptoms usually appear at the beginning of treatment (acute generalized exanthematous pustulosis, rare [may affect up to 1 in 1,000 people]).

Other adverse effects

Very common (may affect more than 1 to up to 10 people)

  • diarrhoea.

Common (may affect up to 1 in 10 people)

  • headache
  • vomiting, stomach pain, nausea
  • changes in blood test results (decreased lymphocyte count, increased eosinophil count, increased basophil count, increased monocyte count, increased neutrophil count, decreased blood bicarbonate).

Uncommon (may affect up to 1 in 100 people)

  • candidiasis: fungal infection of the mouth and vagina, other fungal infections
  • pneumonia, bacterial throat infection, inflammation of the digestive tract, respiratory disorder, inflammation of the nasal mucosa, vaginal infection
  • changes in white blood cell count (leukopenia, neutropenia, eosinophilia)
  • increased platelet count
  • reduction in the proportion of all blood cells in total blood volume (decreased haematocrit)
  • allergic reactions, swelling of the hands, feet and face (angioedema)
  • loss of appetite
  • nervousness, difficulty sleeping (insomnia)
  • dizziness, numbness (somnolence), changes in taste sensation (dysgeusia), tingling or numbness (paraesthesia)
  • vision disturbances
  • ear disorder
  • sensation of spinning (vertigo)
  • awareness of heartbeat (palpitations)
  • hot flushes
  • sudden chest pain, nosebleeds
  • constipation, flatulence, indigestion (dyspepsia), inflammation of the stomach lining (gastritis), difficulty swallowing (dysphagia), bloated abdomen, dry mouth, belching, mouth ulcers, increased salivation
  • skin rash, itching, hives (urticaria), dermatitis, dry skin, abnormally increased sweating (hyperhidrosis)
  • swelling and pain in the joints (osteoarthritis), muscle pain, back pain, neck pain
  • pain when urinating (dysuria), kidney pain
  • irregular menstrual bleeding (metrorrhagia), testicular disorder
  • swelling due to fluid accumulation, especially in the face, ankles and feet (oedema, facial oedema, peripheral oedema)
  • weakness, fatigue, general malaise, fever
  • chest pain, pain
  • abnormal laboratory test results (e.g., blood tests or liver function tests)
  • post-procedural complication.

Rare (may affect up to 1 in 1,000 people)

  • sensation of irritation
  • liver problems, yellowing of the skin or eyes
  • increased sensitivity to sunlight

Frequency not known (cannot be estimated from available data)

  • reduction in red blood cell count due to increased cell breakdown, which may cause fatigue and pale skin (haemolytic anaemia)

  • reduction in blood platelet count, which may cause bleeding and bruising (thrombocytopenia)

  • feeling irritable, aggressive, fearful or worried (anxiety), acute state of confusion (delirium)

  • hallucinations

  • fainting (syncope)

  • seizures (convulsions)

  • decreased sensitivity to touch, pain and temperature (hypoesthesia)

  • feeling hyperactive

  • changes in sense of smell (anosmia, parosmia)

  • complete loss of taste (ageusia)

  • muscle weakness (myasthenia gravis)

  • abnormal electrocardiogram (ECG) trace (prolongation of QT interval)

  • deafness, hearing loss or ringing in the ears (tinnitus)

  • low blood pressure

  • inflammation of the pancreas causing severe abdominal and back pain (pancreatitis)

  • change in tongue colour

  • joint pain (arthralgia)

  • kidney inflammation (interstitial nephritis) and kidney failure.

Reporting of adverse effects

If you experience any type of adverse effect, talk to your doctor, pharmacist or nurse, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Azithromycin Combix

Keep this medicine out of the sight and reach of children.

This medicine does not require special storage conditions. Do not transfer the tablets to another container.

Do not use this medicine after the expiry date stated on the packaging after "Exp.". The expiry date refers to the last day of the month indicated.

Medicines must not be disposed of via wastewater or household waste. Dispose of containers and unused medicines at the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Information for the user

Composition of Azithromycin Combix

  • The active substance is azithromycin. Each tablet contains 500 mg of azithromycin (as azithromycin dihydrate).
  • The other components are: pregelatinized corn starch, crospovidone, anhydrous calcium hydrogen phosphate, sodium lauryl sulfate, magnesium stearate, hypromellose, titanium dioxide (E-171), monohydrate lactose, glyceryl triacetate.

Appearance of the medicine and contents of the pack

Azithromycin Combix 500 mg is presented as white, film-coated, oblong, biconvex tablets, marked on one side.

Each pack contains blisters with 3 or 150 tablets.

Not all pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Laboratorios Combix, S.L.U.

C/ Badajoz 2, Edificio 2

28223- Pozuelo de Alarcon (Madrid)

Spain

Manufacturer:

Bluepharma - Indústria Farmacêutica, S.A.

  • Martinho do Bispo. 3045-016 Coimbra

Portugal

This leaflet was last approved in November 2025.

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/